CN101327233B - Compound external-use formulation for treating gonorrhoea and nongonococcal urethritis - Google Patents
Compound external-use formulation for treating gonorrhoea and nongonococcal urethritis Download PDFInfo
- Publication number
- CN101327233B CN101327233B CN2008101408987A CN200810140898A CN101327233B CN 101327233 B CN101327233 B CN 101327233B CN 2008101408987 A CN2008101408987 A CN 2008101408987A CN 200810140898 A CN200810140898 A CN 200810140898A CN 101327233 B CN101327233 B CN 101327233B
- Authority
- CN
- China
- Prior art keywords
- gonorrhea
- preparation
- parts
- compound external
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 206010018612 Gonorrhoea Diseases 0.000 title claims abstract description 30
- 150000001875 compounds Chemical class 0.000 title claims abstract description 19
- 239000000203 mixture Substances 0.000 title claims abstract description 4
- 208000000143 urethritis Diseases 0.000 title abstract description 5
- 238000009472 formulation Methods 0.000 title abstract 2
- 239000003814 drug Substances 0.000 claims abstract description 36
- 208000001786 gonorrhea Diseases 0.000 claims abstract description 29
- 238000002360 preparation method Methods 0.000 claims abstract description 21
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims abstract description 12
- 239000004098 Tetracycline Substances 0.000 claims abstract description 11
- 235000019364 tetracycline Nutrition 0.000 claims abstract description 11
- 150000003522 tetracyclines Chemical class 0.000 claims abstract description 11
- 229960002180 tetracycline Drugs 0.000 claims abstract description 5
- 229930101283 tetracycline Natural products 0.000 claims abstract description 5
- 241001660870 Cyrtomium Species 0.000 claims abstract description 4
- 239000002994 raw material Substances 0.000 claims abstract description 3
- 239000000843 powder Substances 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- JHJUUEHSAZXEEO-UHFFFAOYSA-M sodium;4-dodecylbenzenesulfonate Chemical compound [Na+].CCCCCCCCCCCCC1=CC=C(S([O-])(=O)=O)C=C1 JHJUUEHSAZXEEO-UHFFFAOYSA-M 0.000 claims description 6
- 229940040944 tetracyclines Drugs 0.000 claims description 6
- 239000006210 lotion Substances 0.000 claims description 4
- 239000011812 mixed powder Substances 0.000 claims description 4
- 239000011435 rock Substances 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 2
- 229940079593 drug Drugs 0.000 abstract description 15
- 241000222122 Candida albicans Species 0.000 abstract description 5
- 241000204031 Mycoplasma Species 0.000 abstract description 5
- 229940095731 candida albicans Drugs 0.000 abstract description 5
- 208000015181 infectious disease Diseases 0.000 abstract description 5
- 241000606161 Chlamydia Species 0.000 abstract description 4
- 201000007094 prostatitis Diseases 0.000 abstract description 4
- 230000003628 erosive effect Effects 0.000 abstract description 3
- 206010046914 Vaginal infection Diseases 0.000 abstract description 2
- 201000008100 Vaginitis Diseases 0.000 abstract description 2
- 230000035876 healing Effects 0.000 abstract 1
- 208000015891 sexual disease Diseases 0.000 abstract 1
- HFQQZARZPUDIFP-UHFFFAOYSA-M sodium;2-dodecylbenzenesulfonate Chemical compound [Na+].CCCCCCCCCCCCC1=CC=CC=C1S([O-])(=O)=O HFQQZARZPUDIFP-UHFFFAOYSA-M 0.000 abstract 1
- 244000052616 bacterial pathogen Species 0.000 description 17
- 230000000694 effects Effects 0.000 description 17
- SNRUBQQJIBEYMU-UHFFFAOYSA-N dodecane Chemical compound CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 10
- 201000010099 disease Diseases 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 210000001215 vagina Anatomy 0.000 description 8
- 244000052769 pathogen Species 0.000 description 7
- 239000008280 blood Substances 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 210000004877 mucosa Anatomy 0.000 description 6
- 238000011084 recovery Methods 0.000 description 6
- 241000588653 Neisseria Species 0.000 description 5
- 210000002700 urine Anatomy 0.000 description 5
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 230000003902 lesion Effects 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 150000003254 radicals Chemical class 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 230000001954 sterilising effect Effects 0.000 description 4
- 238000004659 sterilization and disinfection Methods 0.000 description 4
- 210000003708 urethra Anatomy 0.000 description 4
- 206010059866 Drug resistance Diseases 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000000825 pharmaceutical preparation Substances 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 208000007190 Chlamydia Infections Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 230000001139 anti-pruritic effect Effects 0.000 description 2
- 239000003908 antipruritic agent Substances 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 238000010255 intramuscular injection Methods 0.000 description 2
- 239000007927 intramuscular injection Substances 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 230000004224 protection Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010009168 Chyluria Diseases 0.000 description 1
- 208000004145 Endometritis Diseases 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 201000000628 Gas Gangrene Diseases 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 206010021929 Infertility male Diseases 0.000 description 1
- 206010024238 Leptospirosis Diseases 0.000 description 1
- 208000007466 Male Infertility Diseases 0.000 description 1
- 241000204003 Mycoplasmatales Species 0.000 description 1
- 206010033307 Overweight Diseases 0.000 description 1
- 206010034133 Pathogen resistance Diseases 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 241000606701 Rickettsia Species 0.000 description 1
- 206010039954 Seminal vesiculitis Diseases 0.000 description 1
- 241001180364 Spirochaetes Species 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- 208000009911 Urinary Calculi Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 230000000507 anthelmentic effect Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000001741 anti-phlogistic effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 210000003679 cervix uteri Anatomy 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 201000003511 ectopic pregnancy Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 201000010063 epididymitis Diseases 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000000762 glandular Effects 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 239000007952 growth promoter Substances 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000002969 morbid Effects 0.000 description 1
- 230000001338 necrotic effect Effects 0.000 description 1
- 235000020825 overweight Nutrition 0.000 description 1
- 210000003101 oviduct Anatomy 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 210000003899 penis Anatomy 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000000452 restraining effect Effects 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- MZSDGDXXBZSFTG-UHFFFAOYSA-M sodium;benzenesulfonate Chemical compound [Na+].[O-]S(=O)(=O)C1=CC=CC=C1 MZSDGDXXBZSFTG-UHFFFAOYSA-M 0.000 description 1
- 208000006379 syphilis Diseases 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 201000010653 vesiculitis Diseases 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The invention relates to a compound external preparation for treating gonorrhea and non-gonorrhea, which is prepared by five raw materials of acorn, cyrtomium rhizome, tetracycline, calcined soda and sodium dodecyl benzene sulphonate. The formulation of the preparation is well prepared, the preparation method is simple, and each drug exerts merit and cooperates to treat gonorrhea and non-gonorrhea synthetically. Compared with the prior art, the preparation can effectively deracinate sexual diseases such as gonorrhea, non-gonorrhea and the like caused by various infections such as male urethritis, prostatitis, female vaginitis, cervical erosion which are resulted from diplococcus gonorrhea, candidaalbicans, mycoplasma, chlamydia, infusorium, etc. The preparation has the advantages of fast efficacy, high healing rate, low recurrence rate, being convenient to carry and use, etc.
Description
Technical field
The invention belongs to medical technical field, particularly a kind of compound external-use preparation that is used for the treatment of gonorrhea and non-pouring.
Background technology
Gonorrhea, non-pouring are listed in a big pertinacious disease of puzzlement sufferer, have characteristics such as rapid onset, course of disease length, the difficulty of curing, easy recurrence, are having a strong impact on human healthy and quality of life.Modern medicine study is thought: the non-pouring of gonorrhea is to be caused by gonococcus, Candida albicans, mycoplasma, chlamydia etc.If untimely treatment, gonococcus can enter back urethra or cervix uteri, causes the inflammation of urogenital tract and near organ to vertical spread, as various infection such as skenitis, urethritis, prostatitis, seminal vesiculitis, epididymitis, endometritis, cervical erosion.Gonococcus also can hide in the glandular tissue deep for a long time, becomes chronic gonorrhea, repeatedly outbreak.Connective fiberization can cause deferent duct, uterine tube stegnosis, block, secondary ectopic pregnancy and male sterility after these infected organ inflammation disappeared.
At present, the medicine and the method for treatment gonorrhea, non-pouring are of a great variety, the inclined to one side external of doctor trained in Western medicine overweights bactericidal antiphlogistic, for oral administration then many, hormones quick with breath, Tri-Biocin are treated, dispenser many again with takes orally, transfusion or intramuscular injection, all be to circulate kill pathogens by the body inner blood, this just causes and can not come kill pathogens with the strong dose thing, and pathogenic bacteria is in order to adapt to surrounding, and self can morph, and produces drug resistance.Simultaneously, the medicine 80% that is used for kill pathogens is discharged to external by Liver and kidney, have only a spot of medicine to reach lesions position by blood capillary, and medicine is behind renal metabolism, and the drug effect usefulness when reaching focus subtracts greatly and is inadequate, and takes for a long time, side effect to human body is big, cause the human body immunocompetence to descend, and be not suitable for continuous use, therefore be difficult to reach the effect of thorough radical cure.Thereby have weak curative effect, take effect slow, treatment time is long, drug resistance by force, obstinate, toxic and side effects is big, especially to defectives such as the damage of liver are bigger.Chinese medicine then thinks, gonorrhea mean urinate not smooth, drop and descending, even disease such as have a pain in the stem and is divided into five types of stranguria, i.e. stranguria with blood, stranguria caused by urinary stone, qi stranguria, stranguria marked by chyluria, stranguria caused by overstrain.Pathogenesis loses for unit is empty down, clear QI being mixed up with turbid QI, and kidney qi is not all right, and pent-up is for drenching.Its dialectical executing is controlled with clearing away heat and promoting diuresis, and it is main removing the humidifying pouring.In the prior art, the prescription of the non-pouring of treatment gonorrhea is a lot, and the determined curative effect person is less, thereby is difficult for promoting.
Summary of the invention
The purpose of this invention is to provide a kind of rapid-action, determined curative effect, cure rate height, the compound external-use preparation that is used for the treatment of gonorrhea and non-pouring that relapse rate is low.
For achieving the above object, external used medicine of the present invention is to be made by the following medicaments in part by weight raw material: 100～200 parts of acorn nuts, 30～50 parts of Rhizoma Osmundae, 10～20 parts of tetracyclines, 70～80 parts of soda, 10～20 parts of dodecylbenzene sodium sulfonate.
Externally applied compound medicinal preparation of the present invention prepares by following step:
(1) gets acorn nut and clean, dry, shell, get Rhizoma Osmundae and mix clearly, clean, dry, the two pulverize separately is made Powdered standby;
(2) get the acorn nut and the Cyrtomium Rhizome of tetracycline, soda, the basic benzene sulfonic acid sodium salt of dodecane and preparation respectively by described prescription proportioning, mixing is milled, and crosses 280 mesh sieves, promptly makes compound external-use powder of the present invention;
When (3) using, with mixed powder by medicated powder: the weight portion proportioning of water=5: 1000～2000 adds water, rocks or stirs, and mixed powder is all dissolved, and promptly makes compound external-use lotion of the present invention.
The inventor passes through the long-term theory research of gonorrhea, non-pouring and a large amount of clinical practices, and widely collecting and Zhen Jian in conjunction with the classical treatise of Chinese and western medical science at all times, think why refractory and easily dying of this disease, more repeatedly, its main cause is: the one, cause the pathogenic bacteria of gonorrhea, non-pouring to be hidden growing of living in be difficult for executing control, as cause gonorrhea by gonococcus, generally be present in the multinuclear leucocyte; The mycoplasma, the chlamydia that cause non-pouring then are the microorganisms that parasitizes human body, main parasitic is in the cell of vagina, urethral mucosa, and Candida albicans belongs to a kind of of fungus, colonizes in human body cell gap or pore, the pore, outer rule of treatment difficulty reaches focus, and treatment by oral administration of medicines also is difficult for gathering effect.The 2nd, antibiotics is adopted in conventional treatment more, many again with transfusion or intramuscular injection, circulate kill pathogens by the body inner blood, have only a spot of medicine to reach lesions position by blood capillary, and that the medicine 80% that is used for kill pathogens is discharged to by Liver and kidney is external, so form obstinate.The 3rd, for oral administration or injecting drug use measure and then is not enough to kill pathogens for a short time, also long-term prescription cause variability of pathogenic bacteria self and drug resistance to strengthen again, and the medication metering is excessive, easily causes lesions of liver and kidney again, though so sterilization good medicine is arranged, and the doctor is at a loss to know how to conduct.The 4th, the present method of controlling of executing is difficult to change the environment that pathogenic bacteria grows, brings back to life, and can not thoroughly cure so can only change its surface symptoms, and cause more and regenerate, and gives birth to and the morbid state circulation controlled again.
Based on above-mentioned, the approach of controlling of executing of the present invention is: carry out exterior washings by the strong dose thing, directly be sprinkled upon around the pathogenic bacteria, make it infiltrate lesions position, kill pathogens lentamente.Vagina, urethral mucosa can absorb a part of medicine simultaneously, and this part medicine can kill the pathogenic bacteria that does not contact medicine by blood circulation.Its sterilization mechanism is because pathogenic bacteria also has the skin care film of self; the protection external environment is to its adverse effect, and in the application of soda and the sour environment of the existence of pathogenic bacteria, can tear the protecting film of pathogenic bacteria; it is proteinic synthetic to make bactericide can thoroughly block pathogenic bacteria, can make pathogenic bacteria death rapidly.Acorn nut can make normal human body cell fine and close rapidly, but can not normal contraction by the cell of mycoplasma, chlamydia infection, thereby make it isolated, help the strong dose thing pathogenic bacteria is is thoroughly catched and killed, and remove dead pathogenic bacteria and downright bad slough, keep vagina, urethra cleaning by dodecylbenzene sodium sulfonate, promote the recovery of vagina, urethral mucosa, change pathogenic bacteria and bring back to life, grow environment, sick portion can thoroughly effect a radical cure naturally, and can avoid recurrence effectively.The concrete function of each component drug is respectively in the prescription of the present invention:
Acorn nut: can strengthen immune function of human body, promote growth promoter, cellular metabolism is used for removing the necrotic tissue and promoting granulation, repairs vagina, urethral mucosa.
Rhizoma Osmundae: have heat-clearing and toxic substances removing, cooling blood for hemostasis, the parasite killing anthelmintic, effect such as antibacterial grade is used for sterilization, sterilization, protection vagina, urethral mucosa.
Tetracycline: gram positive bacteria, negative bacterium, rickettsia, filterable virus, Spirochaetes and even former insects are all had the good restraining effect, to the certain antibacterial activity of gonococcus tool, be used for the treatment of tetanus, gas gangrene, syphilis, gonorrhea and the leptospirosis etc. of penicillin anaphylaxis.
Soda: can in and the sour environment around the pathogenic bacteria, and can make the film rupture of pathogenic bacteria epidermis protected acidic.
Dodecylbenzene sodium sulfonate: be used to remove dead pathogenic bacteria and downright bad slough, keep vagina, urethra cleaning, promote the recovery of vagina, urethral mucosa.
Compound external-use preparation of the present invention adopts Chinese medicine and western medicine to cooperate at the pathological characters of various gonorrheas, non-pouring, and its prescription compatibility is proper, and preparation method is simple, and respectively executes its length by each component drug, and synergism comprehensively effects a radical cure disease.Compared with prior art, said preparation can be eradicated property diseases such as the gonorrhea that various infection such as the various male urethra inflammation that have gonorrhea diplococcus, Candida albicans, mycoplasma, chlamydia, infusorian etc. to cause, prostatitis, women vaginitis, cervical erosion cause, non-pouring effectively, and have instant effect, cure rate height, relapse rate low, portably use advantages such as convenient.
The specific embodiment
Compound external-use preparation of the present invention is by the long-pending ten several years convection potential gonorrheas of inventor, non-pouring pathogenesis and executes the concentrated research of administering opinion and medical record at all times, and by a large amount of clinical practices and test gained, each component of its medicine all has curative effect preferably in the following weight parts ratio range: 100～200 parts of acorn nuts, 30～50 parts of Rhizoma Osmundae, 10～20 parts of tetracyclines, 70～80 parts of soda, 10～20 parts of dodecylbenzene sodium sulfonate.
Embodiment 1
The weight portion proportioning of each component drug of externally used compound pharmaceutical preparation of the present invention can be: 100 parts of acorn nuts, 30 parts of Rhizoma Osmundae, 10 parts of tetracyclines, 70 parts of soda, 10 parts in the basic sour sodium of dodecane.
Embodiment 2
The weight portion proportioning of each component drug of externally used compound pharmaceutical preparation of the present invention also can be: 150 parts of acorn nuts, 40 parts of Rhizoma Osmundae, 15 parts of tetracyclines, 75 parts of soda, 15 parts in the basic sour sodium of dodecane.
Embodiment 3
The weight portion proportioning of each component drug of externally used compound pharmaceutical preparation of the present invention can also be: 200 parts of acorn nuts, 50 parts of Rhizoma Osmundae, 20 parts of tetracyclines, 80 parts of soda, 20 parts in the basic sour sodium of dodecane.
The preparation method of medicine of the present invention is:
Get acorn nut (shelling), Rhizoma Osmundae, removal of contamination, and pulverize and to make powder then, takes by weighing tetracycline, soda, the basic sour sodium of dodecane and acorn nut and Cyrtomium Rhizome respectively by described proportional quantity and mixes and mill evenly, crosses 280 mesh sieves, promptly makes the compound external-use powder.Its amount by every bag 5 gram is encapsulated in the bag, during use, adds in the entry, stir or rock even, medicated powder is all dissolved, promptly make the compound external-use lotion by the proportioning of medicated powder and water: 5g: 1～2kg.Clean affected part repeatedly with this lotion, according to state of an illness weight is for 20 times a course of treatment, clean 1 first every day course of treatment, clean once second per 3～5 days of course of treatment, each wash number successive doubling blanking time prolongation course of treatment later on, 1～2 course of treatment of general treatment, severe patient uses just can fully recover 3～4 courses of treatment.Use pharmaceutical treatment gonorrhea of the present invention and non-gonorrhea, can be after the recovery from illness generally not in recurrence.
External preparation of the present invention uses for many years patient Shi Zhi through the inventor, case 1286 examples are followed up a case by regular visits in tracking, therapeutic effect is obvious, the obvious alleviator of clinical symptoms reaches 1272 examples, obvious effective rate reaches 98.9%, 1222 examples of thoroughly fully recovering, cure rate reaches more than 95%, has followed up a case by regular visits to recidivist's 11 examples, and relapse rate is just controlled the patient and gasp in admirationd gratitude invariably less than 1%.
Experiment case 1
Mr. Xia infected gonorrhea in 18 years old, because the shy psychology of sufferer fails in time to cure, caused bacterial resistance, formed chronicly, and medical history more than 11 year is cured for a long time in many ways, and effect is all undesirable, once repeatedly want to remove to commit suiside misery.Seek medical advice to this clinic in March, 2003, and clinical symptoms is: the urine mouth is suppurated, and is yellow green, and abnormal flavour is arranged, very itch unbearably, and the urine twinge, urine once urine is exactly once painful, unbearably puzzlement.Through using external preparation of the present invention, only itched in 4 days every day 1 time, clean 20 days table diseases and disappear substantially, cleaned medication once in per 3 days the 2nd, 3 courses of treatment, recovery from illness after 3 months, disease is all eliminated, and follows up a case by regular visits to and does not have recurrence more so far.
Experiment case 2
Lee XX, male, 42 years old, the worker of Henan Province Affiliated Hospital of the college of traditional Chinese medicine, suffer from mycoplasma, chlamydia infection more than 8 years, the multi-treatment poor effect, seek medical advice to this clinic in March, 1998, clinical examination, the urine mouth drips white, red and swollen, and urethra is very itched, the concomitant infections prostatitis, clean through using externally-applied powder water distribution of the present invention, the same day can be antipruritic, cleaned 1 time in later per three days, and 20 times is a course of treatment, the 2nd course of treatment, jede Woche cleans medication once, and the 3rd, 4 course of treatment, every fortnight cleans medication once, thoroughly recovery from illness after 4 courses of treatment is followed up a case by regular visits to and is not had recurrence more so far.
Experiment case 3
Mr. Wang, 44 years old, Nanyang Wancheng District basin kiln village people, infection by Candida albicans is for 7 years, and is bad during fashion, never radical cure.Ill existing 12 years history is repeatedly cured through province, city-level hospital, and effect is undesirable.Cure to this clinic February calendar year 2001, and through valuing, glans penis turns white, dirty sample is arranged, and it is hard to bear very to itch, cleans through using externally-applied powder water distribution of the present invention, after medication in first day is cleaned, can be antipruritic, the 1st, 2 course of treatment, medication every day is cleaned once, the 3rd course of treatment, medication in per three days is cleaned once, after the recovery from illness, follows up a case by regular visits to and does not have recurrence more so far.
Claims (2)
1. compound external-use preparation that is used for the treatment of gonorrhea and non-pouring, it is characterized in that: it is to be made by the following medicaments in part by weight raw material: 100～200 parts of acorn nuts, 30～50 parts of Rhizoma Osmundae, 10～20 parts of tetracyclines, 70～80 parts of soda, 10～20 parts of dodecylbenzene sodium sulfonate.
2. the preparation method of the compound external-use preparation of described treatment gonorrhea of claim 1 and non-pouring, it is characterized in that: it is to be undertaken by following step:
(1) gets acorn nut and clean, dry, shell, get Rhizoma Osmundae and mix clearly, clean, dry, the two pulverize separately is made Powdered standby;
(2) get the acorn nut and the Cyrtomium Rhizome of tetracycline, soda, dodecylbenzene sodium sulfonate and preparation respectively by described prescription proportioning, mixing is milled, and crosses 280 mesh sieves, promptly makes the compound external-use powder;
When (3) using, with mixed powder by medicated powder: the weight portion proportioning of water=5: 1000～2000 adds water, rocks or stirs, and mixed powder is all dissolved, and promptly makes the compound external-use lotion.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008101408987A CN101327233B (en) | 2008-08-04 | 2008-08-04 | Compound external-use formulation for treating gonorrhoea and nongonococcal urethritis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008101408987A CN101327233B (en) | 2008-08-04 | 2008-08-04 | Compound external-use formulation for treating gonorrhoea and nongonococcal urethritis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101327233A CN101327233A (en) | 2008-12-24 |
| CN101327233B true CN101327233B (en) | 2010-08-25 |
Family
ID=40203388
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2008101408987A Expired - Fee Related CN101327233B (en) | 2008-08-04 | 2008-08-04 | Compound external-use formulation for treating gonorrhoea and nongonococcal urethritis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101327233B (en) |
-
2008
- 2008-08-04 CN CN2008101408987A patent/CN101327233B/en not_active Expired - Fee Related
Non-Patent Citations (4)
| Title |
|---|
| 姚五原.四种常见性病简介.医药养生保健报.2006,第013版. * |
| 张运昌.非淋菌性阴道炎如何治.家庭医药.2004,48. * |
| 钱桐荪.尿路感染的治疗.中国中西医结合肾病杂志.2001,2(4),187-189. * |
| 陈伯崇.急性淋病性尿道炎98例诊治.华西医讯.1989,4(4),457-458. * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101327233A (en) | 2008-12-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103316262B (en) | A kind of gynecological external antibacterial liquid and preparation method thereof | |
| CN101874809A (en) | Local anti-inflammatory external medicinal composition using glycerol DMSO mixed solvent | |
| CN102379941B (en) | A kind of compound Chinese medicinal preparation treating fracture and preparation method thereof | |
| CN105251011A (en) | Membrane-spraying agent for superficial burns and preparation method thereof | |
| CN104274741A (en) | Medicinal composition and medicinal sanitary napkin for treating gynecological diseases | |
| CN104721418B (en) | It is a kind of to be used to treat pharmaceutical composition of gynaecological imflammation and preparation method thereof and purposes | |
| CN106619780A (en) | Gynecological antibacterial gel | |
| CN103566071B (en) | Traditional Chinese medicine composition for treating ulcer and preparation method of powder of traditional Chinese medicine composition | |
| CN102716281B (en) | Care solution for cleaning wounds after operation | |
| RU2530605C2 (en) | Composition for injections, which contains hydroxychloroquine, for local application in treatment of haemorrhoid | |
| CN101327233B (en) | Compound external-use formulation for treating gonorrhoea and nongonococcal urethritis | |
| CN102552665B (en) | Externally-applied traditional Chinese medicine composition for treating gynecological diseases | |
| CN109771595A (en) | A kind of Chinese medicine composition and preparation method thereof for treating gynaecological imflammation | |
| CN102727799A (en) | Traditional Chinese medicine composition for treating female cervical erosion | |
| CN1899412A (en) | Suppository for treating gynecopathy and its preparing method | |
| CN109908304A (en) | Chinese medicine composition and application thereof, traditional Chinese medicine for outer use and preparation method thereof | |
| CN103565921A (en) | Specific medicine for treating bedsore and promoting quick healing of wound | |
| CN102366567B (en) | Pharmaceutical composition for treating condyloma acuminatum, and preparation and application method | |
| CN107029160A (en) | It is a kind of that there is heat-clearing and damp-drying drug, pharmaceutical composition of the antipruritic function of desinsection and preparation method thereof | |
| CN106039239B (en) | A kind of Chinese materia medica preparation that treating female infertility, preparation method and its usage | |
| CN107583050A (en) | A kind of pharmaceutical composition and purposes for being used to treat cervicitis | |
| CN101618118B (en) | Application of traditional Chinese medicine composition in preparation of medicine for treating cystitis | |
| CN104055734A (en) | Traditional Chinese medicinal composition for treating vaginitis and preparation method of foam aerosol thereof | |
| CN105477418A (en) | Traditional Chinese medicinal preparation for treating urinary system infection | |
| CN116763891A (en) | Traditional Chinese medicine composition for treating pelvic inflammatory disease and infertility caused by pelvic inflammatory disease |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20100825 Termination date: 20180804 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |